We aimed to explore the prognostic value of albumin–bilirubin (ALBI) scores in unresectable hepatocellular carcinoma (HCC) treated with combined immune checkpoint inhibitors (ICIs) and radiotherapy (RT). Click to show full abstract
We aimed to explore the prognostic value of albumin–bilirubin (ALBI) scores in unresectable hepatocellular carcinoma (HCC) treated with combined immune checkpoint inhibitors (ICIs) and radiotherapy (RT).
               
Click one of the above tabs to view related content.